Fresenius Strikes $250M Deal To Settle Dialysis Drug MDL
Fresenius Medical Care said Wednesday it has reached a $250 million agreement in principle to settle multidistrict litigation over the alleged side effects from dialysis drugs GranuFlo and NaturaLyte, a day...To view the full article, register now.
Already a subscriber? Click here to view full article